Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Which psychedelics should we start with? - Neural Therapeutics

Which psychedelics should we start with? - Neural Therapeutics

Neural Therapeutics Inc. Scientific Advisor Professor David Nutt answers some of the questions raised by his recent presentation on the potentially revolutionary untapped effects of psychedelic medicine

Today's questions is: Which psychedelics would you recommend we start with and which ones should we stay away from?

The presentation itself focused on what Professor Nutt describes as the utility of psychedelic compounds and their potential to transform the treatment of mental illness.

Neural Therapeutics is a drug-discovery company focusing on plant-based active substances with the goal of delivering beneficial, over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments where no significant treatment is available today.